The Ser219–>Gly dimorphism of the endothelial protein C receptor contributes to the higher soluble protein levels observed in individuals with the A3 haplotype

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Journal of Thrombosis and Haemostasis

• Publication date

  2006-01-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/j.1538-7836.2005.01676.xPMID 16409473
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A haplotype of the EPCR gene is associated with increased plasma levels of sEPCR and is a candidate risk factor for thrombosis.

  2004cited by this paper
• Patients with severe sepsis vary markedly in their ability to generate activated protein C.

  2004cited by this paper
• Haplotypes of the EPCR gene, plasma sEPCR levels and the risk of deep venous thrombosis

  2004cited by this paper
• The Crystal Structure of the Endothelial Protein C Receptor and a Bound Phospholipid*

  2002cited by this paper
• Metalloproteolytic Release of Endothelial Cell Protein C Receptor*

  2000cited by this paper
• The Endothelial Cell Protein C Receptor

  2000cited by this paper
• The protein C pathway

  2000cited by this paper
• Reconstitution of the Human Endothelial Cell Protein C Receptor with Thrombomodulin in Phosphatidylcholine Vesicles Enhances Protein C Activation*

  1999cited by this paper
• Identification of functional endothelial protein C receptor in human plasma.

  1997cited by this paper
• The endothelial cell protein C receptor augments protein C activation by the thrombin-thrombomodulin complex.

  1996cited by this paper
• Identification, cloning, and regulation of a novel endothelial cell protein C/activated protein C receptor.

  1994cited by this paper
• The structure and function of mouse thrombomodulin. Phorbol myristate acetate stimulates degradation and synthesis of thrombomodulin without affecting mRNA levels in hemangioma cells.

  1988cited by this paper
• Identifying nonpolar transbilayer helices in amino acid sequences of membrane proteins.

  1986cited by this paper
• International Society on Thrombosis and Haemostasis

  1974cited by this paper

• Genetic determinants of activated factor VII-antithrombin plasma levels and mortality in patients with coronary artery disease.

  2025cites this paper
• Endothelial Protein C Receptor and Its Impact on Rheumatic Disease

  2024cites this paper
• The association between EPCR gene p.Ser219Gly polymorphism and venous thromboembolism risk: a case–control study, meta-analysis, and a reproducibility study

  2023cites this paper
• Thrombogenesis-associated genetic determinants as predictors of thromboembolism and prognosis in cervical cancer

  2023cites this paper
• An Exploratory Study Using Next-Generation Sequencing to Identify Prothrombotic Variants in Patients with Cerebral Vein Thrombosis

  2023cites this paper
• Elucidating mechanisms of genetic cross-disease associations at the PROCR vascular disease locus

  2022cites this paper
• Elucidating mechanisms of genetic cross-disease associations at the PROCR vascular disease locus

  2022cites this paper
• Thrombotic risk determined by protein C receptor (PROCR) variants among middle-aged and older adults: a population-based cohort study

  2022cites this paper
• Are H1 and H3 haplotypes of endothelial protein C receptor (PROCR) an important factor in contracting COVID‐19?

  2022cites this paper
• Elucidating mechanisms of genetic cross-disease associations: an integrative approach implicates protein C as a causal pathway in arterial and venous diseases

  2020cites this paper
• Venous thromboembolism GWAS reported genetic makeup and the hallmarks of cancer: Linkage to ovarian tumour behaviour.

  2019cites this paper
• The H3 Haplotype of the EPCR Gene Determines High sEPCR Levels in Critically Ill Septic Patients

  2018cites this paper
• The H1 haplotype of the endothelial protein C receptor protects against arterial thrombosis in patients with antiphospholipid syndrome.

  2018cites this paper
• Associations of activated coagulation factor VII and factor VIIa‐antithrombin levels with genome‐wide polymorphisms and cardiovascular disease risk

  2018cites this paper
• Fifteen new risk loci for coronary artery disease highlight arterial-wall-specific mechanisms

  2017cites this paper
• The comparison of the Levels of Soluble Endothelial Protein C Reseptor in Mild And Severe Preeclamptic Group with Normotensive Group at Third Trimester

  2017cites this paper
• α-Cyperone Inhibits PMA-Induced EPCR Shedding through PKC Pathway.

  2017cites this paper
• EPCR Gene Ser219Gly Polymorphism and Venous Thromboembolism: A Meta-Analysis of 9,494 Subjects

  2017cites this paper
• Zingerone Suppresses the Shedding of Endothelial Protein C Receptor

  2017cites this paper
• Suppressive effects of dabrafenib on endothelial protein C receptor shedding

  2016cites this paper
• Suppressive Effects of Pelargonidin on Endothelial Protein C Receptor Shedding via the Inhibition of TACE Activity and MAP Kinases.

  2016cites this paper
• Three Coagulation Related Mutations and Increased Risk of Myoma in Women of Fars Province

  2016cites this paper
• Relation between Endothelial Protein C Receptor Gene Polymorphisms rs867186 and rs9574, and the Risk of Deep Vein Thrombosis in Sudanese

  2016cites this paper
• Suppressive effects of polyozellin on endothelial protein C receptor shedding via inhibiting TACE activity and MAP kinases.

  2016cites this paper
• Inhibitory effects of three diketopiperazines from marine-derived bacteria on endothelial protein C receptor shedding in human endothelial cells and mice.

  2016cites this paper
• Role of EPCR in breast cancer progression and metastasis

  2015cites this paper
• Protein C system defects inflicted by the malaria parasite protein PfEMP1 can be overcome by a soluble EPCR variant

  2015cites this paper
• Anti-inflammatory effects of vicenin-2 and scolymoside in vitro and in vivo

  2015cites this paper
• Endothelial protein C receptor gene 6936A/G single-nucleotide polymorphism as a possible biomarker of thrombotic risk in acute myeloid leukemia.

  2015cites this paper
• Inhibitory effects of lysozyme on endothelial protein C 1receptor shedding in vitro and in vivo

  2015cites this paper
• Aspalathin and nothofagin from rooibos (Aspalathus linearis) inhibit endothelial protein C receptor shedding in vitro and in vivo.

  2015cites this paper
• Anti-inflammatory effects of methylthiouracil in vitro and in vivo.

  2015cites this paper
• Rôle de la Protéine C, un anticoagulant naturel, dans l’association thrombose et cancer

  2015cites this paper
• Haplotypes of the endothelial protein C receptor (EPCR) gene are not associated with severe malaria in Tanzania

  2015cites this paper
• Anti-Inflammatory Effects of Hyperoside in Human Endothelial Cells and in Mice

  2015influential citation
• Functional Analysis of Two Haplotypes of the Human Endothelial Protein C Receptor Gene

  2014influential citation
• Genetic Markers Associated With Plasma Protein C Level in African Americans: The Atherosclerosis Risk in Communities (ARIC) Study

  2014influential citation
• Piperlonguminine Downregulates Endothelial Protein C Receptor Shedding In Vitro and In Vivo

  2014influential citation
• Inhibitory effects of oroxylin A on endothelial protein C receptor shedding in vitro and in vivo

  2014influential citation
• Anti-inflammatory Effects of Baicalin, Baicalein, and Wogonin In Vitro and In Vivo

  2014cites this paper
• Inhibitory Effects of Rutin on the Endothelial Protein C Receptor Shedding In Vitro and In Vivo

  2014cites this paper
• Withaferin A is an inhibitor of endothelial protein C receptor shedding in vitro and in vivo.

  2014cites this paper
• Exendin-4 inhibits endothelial protein C receptor shedding in vitro and in vivo.

  2014cites this paper
• Anti-septic Effects of Fisetin In Vitro and In Vivo

  2014cites this paper
• Cudratricusxanthone A inhibits endothelial protein C receptor shedding in vitro and in vivo

  2014cites this paper
• potential functional implications Endothelial cell protein C receptor cellular localization and trafficking

  2014cites this paper
• Vascular barrier protective effects of orientin and isoorientin in LPS-induced inflammation in vitro and in vivo.

  2014cites this paper
• Sulforaphane inhibits endothelial protein C receptor shedding in vitro and in vivo.

  2014cites this paper
• Plasmodium falciparum picks (on) EPCR.

  2014cites this paper
• Rosmarinic acid down-regulates endothelial protein C receptor shedding in vitro and in vivo.

  2013cites this paper
• Emodin-6-O-β-d-glucoside down-regulates endothelial protein C receptor shedding

  2013influential citation
• Inhibitory effects of purpurogallin on the endothelial protein C receptor shedding in vitro and in vivo

  2013cites this paper
• Effects of Lycopene on Endothelial Protein C Receptor Shedding In Vitro and In Vivo

  2013cites this paper
• endotoxemia in mice Effects of membrane and soluble EPCR on the hemostatic balance and

  2013cites this paper
• Inhibitory effects of epi-sesamin on endothelial protein C receptor shedding in vitro and in vivo

  2013cites this paper
• Targeted Gene Sequencing Identifies Variants in the Protein C and Endothelial Protein C Receptor Genes in Patients With Unprovoked Venous Thromboembolism

  2013influential citation
• Association of the Thrombomodulin Gene c.1418C>T Polymorphism With Thrombomodulin Levels and With Venous Thrombosis Risk

  2013cites this paper
• Down-regulation of endothelial protein C receptor shedding by persicarin and isorhamnetin-3-O-galactoside.

  2013cites this paper
• Emodin-6-O-β-d-glucoside down-regulates endothelial protein C receptor shedding

  2013influential citation
• Endothelial protein C receptor expressed by ovarian cancer cells as a possible biomarker of cancer onset

  2012cites this paper
• Association of soluble endothelial protein C receptor plasma levels and PROCR rs867186 with cardiovascular risk factors and cardiovascular events in coronary artery disease patients: The Athero Gene Study

  2012cites this paper
• The endothelial protein C receptor (PROCR) Ser219Gly variant and risk of common thrombotic disorders: a HuGE review and meta-analysis of evidence from observational studies.

  2012cites this paper
• Genome wide association study for plasma levels of natural anticoagulant inhibitors and protein C anticoagulant pathway: the MARTHA project

  2012cites this paper
• Soluble endothelial protein C receptor (sEPCR) is likely a biomarker of cancer-associated hypercoagulability in human hematologic malignancies

  2012cites this paper
• Haplotypes of the endothelial protein C receptor gene and Behçet's disease.

  2012cites this paper
• Role of the endothelial cell protein C receptor in thrombosis

  2012cites this paper
• Elevated soluble endothelial cell protein C receptor (sEPCR) levels in women with preeclampsia: a marker of endothelial activation/damage?

  2012cites this paper
• High levels of protein C are determined by PROCR haplotype 3

  2011cites this paper
• The endothelial cell protein C receptor: its role in thrombosis.

  2011cites this paper
• Relationship between endothelial cell protein C receptor gene 6936A/G polymorphisms and deep venous thrombosis.

  2011cites this paper
• Lessons from genome‐wide association studies in venous thrombosis

  2011cites this paper
• Inherited Thrombophilia and the Risk of Vascular Events

  2011cites this paper
• The endothelial cell protein C receptor: cell surface conductor of cytoprotective coagulation factor signaling

  2011cites this paper
• Circulating Endothelial Cell Protein C Receptor: Endothelial Regulation and Cumulative Impact of Gender and A3 Haplotype

  2011cites this paper
• The endothelial cells downregulate the generation of factor VIIa through EPCR binding

  2010cites this paper
• Deciphering the molecular basis of venous thromboembolism: where are we and where should we go?

  2010cites this paper
• Endothelial cell activated protein C receptor (EPCR) and the risk of thrombosis

  2010cites this paper
• The A6936G polymorphism of the endothelial protein C receptor gene is associated with the risk of unexplained foetal loss in Mediterranean European couples

  2009cites this paper
• FVII, FVIIa, and Downstream Markers of Extrinsic Pathway Activation Differ by EPCR Ser219Gly Variant in Healthy Men

  2009cites this paper
• Soluble protein C receptor: why?

  2008cites this paper
• Endothelial cell protein C receptor and the risk of venous thrombosis

  2008cites this paper
• Sizing up platelet defects

  2008cites this paper
• Endothelial protein C receptor polymorphisms and risk of myocardial infarction

  2008cites this paper
• Alternative mRNA is favored by the A3 haplotype of the EPCR gene PROCR and generates a novel soluble form of EPCR in plasma.

  2008cites this paper
• Endothelial cell protein C receptor cellular localization and trafficking: potential functional implications.

  2008cites this paper
• Endothelial cell protein C receptor and the risk of venous thrombosis

  2008cites this paper
• PROC, PROCR and PROS1 polymorphisms, plasma anticoagulant phenotypes, and risk of cardiovascular disease and mortality in older adults: the Cardiovascular Health Study

  2008cites this paper
• Endothelial Cell Protein C Receptor Acts as a Cellular Receptor for Factor VIIa on Endothelium*

  2007cites this paper
• 6A.2 Inherited thrombophilia and pregnancy loss

  2007cites this paper
• Effects of membrane and soluble EPCR on the hemostatic balance and endotoxemia in mice.

  2007cites this paper
• Polymorphisms in the endothelial protein C receptor gene and thrombophilia

  2007cites this paper
• Mechanisms of thrombophilia

  2007cites this paper
• Regulated endothelial protein C receptor shedding is mediated by tumor necrosis factor‐α converting enzyme/ADAM17

  2007cites this paper
• Mechanisms of thrombophilia.

  2007cites this paper
• Microparticles of human atherosclerotic plaques enhance the shedding of the tumor necrosis factor-alpha converting enzyme/ADAM17 substrates, tumor necrosis factor and tumor necrosis factor receptor-1.

  2007cites this paper
• The endothelial protein C receptor

  2006cites this paper